Opportunity
Simpler Grants.gov #HT942526PCARPIDA
Grant Opportunity for Innovative Pancreatic Cancer Research Projects
Buyer
Department of the Army -- USAMRAA
Posted
May 04, 2026
Respond By
October 07, 2026
Identifier
HT942526PCARPIDA
NAICS
541715
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering grant funding for innovative pancreatic cancer research: - Managed under the Congressionally Directed Medical Research Programs (CDMRP) - Seeks high-risk/high-reward research projects with potential for major advancements in pancreatic cancer outcomes - Requires applicants to provide preliminary data relevant to their proposed research - Supports clinical research studies, but clinical trials are not permitted - Offers a Partnering Principal Investigator (PI) option for early-career investigators to collaborate with experienced mentors, with higher funding caps - Anticipates funding approximately 12 awards, with a total program budget of $9.9 million - Single PI applications: up to $0.70M each - Partnering PI applications: up to $0.95M each - Maximum period of performance for each award is 3 years - No specific OEMs, vendors, or product procurements are involved, as this is a research grant opportunity
Description
The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports innovative, high-risk/high-reward research aimed at critical discoveries or major advancements to improve outcomes for individuals with pancreatic cancer. This award requires preliminary data relevant to the proposed project and supports clinical research studies but not clinical trials. There is a Partnering Principal Investigator option for early-career investigators to collaborate with experienced mentors. The program expects to fund approximately 12 awards with a total funding of $9.9 million.